600763.SHG Top Choice Medical Investment Co Inc
- Market cap
- CNY 16.7B
- P/E
- 25.6x
- P/B
- 3.88x
- ROE
- 21.0%
- Dividend yield
- 1.25%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600763.SHG undervalued?
Graham number600763.SHG trades 110.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Top Choice Medical Investment Co Inc fundamental analysis
No fundamental analysis for Top Choice Medical Investment Co Inc yet.
Top Choice Medical Investment Co Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Top Choice Medical Investment Co Inc
Topchoice Medical Co., Inc. offers oral medical services in China. The company is involved in the sale of medical equipment, daily necessities, disinfection products, investment management, import and export business, technology development, technology consulting and technology services, and training services, as well as offers dental medical services. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Co., Inc.…
Full company profileTop Choice Medical Investment Co Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Top Choice Medical Investment Co Inc annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 879M | 1.18B | 1.55B | 1.93B | 2.09B | 2.78B | 2.72B | 2.85B | 2.87B | 2.91B | 3.34B |
| Gross Profit | 363M | 488M | 669M | 882M | 943M | 1.28B | 1.11B | 1.10B | 1.11B | 1.13B | 1.45B |
| Operating Income | 165M | 281M | 439M | 639M | 679M | 975M | 734M | 712M | 699M | 714M | 1.06B |
| EBITDA | 224M | 335M | 496M | 690M | 713M | 1.00B | 817M | 780M | 779M | 935M | 1.23B |
| Net Income | 136M | 217M | 332M | 466M | 493M | 703M | 548M | 500M | 501M | 502M | 893M |
| EPS | 0.42 | 0.68 | 1.04 | 1.45 | 1.54 | 2.19 | 1.71 | 1.56 | 1.12 | 1.12 | 2.00 |
| Balance Sheet | |||||||||||
| Total Assets | 1.29B | 1.79B | 2.13B | 2.66B | 3.06B | 4.95B | 5.15B | 6.01B | 6.18B | 6.04B | 6.25B |
| Total Liabilities | 387M | 695M | 685M | 690M | 716M | 1.81B | 1.54B | 1.88B | 1.82B | 1.47B | 1.56B |
| Shareholders' Equity | 818M | 993M | 1.32B | 1.79B | 2.15B | 2.88B | 3.31B | 3.81B | 4.03B | 4.23B | 4.25B |
| Cash & Short-term Investments | 283M | 560M | 350M | 483M | 674M | 844M | 630M | 594M | 622M | 696M | 618M |
| Total Debt | 260M | 500M | 455M | 380M | 285M | 1.30B | 1.15B | 1.27B | 1.31B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 161M | 347M | 469M | 648M | 708M | 939M | 670M | 840M | 763M | 811M | - |
| Capital Expenditure | 98.4M | 68.7M | 241M | 126M | 170M | 367M | 422M | 509M | 332M | 246M | 237M |
| Free Cash Flow | 62.6M | 278M | 229M | 522M | 538M | 572M | 249M | 335M | 431M | 565M | 811M |
| Ratios | |||||||||||
| ROE | 16.7% | 21.8% | 25.3% | 26.1% | 22.9% | 24.4% | 16.6% | 13.1% | 12.4% | 11.9% | 21.0% |
| ROA | 10.6% | 12.1% | 15.6% | 17.5% | 16.1% | 14.2% | 10.6% | 8.3% | 8.1% | 8.3% | 14.3% |
| Net Profit Margin | 15.5% | 18.4% | 21.5% | 24.1% | 23.6% | 25.3% | 20.2% | 17.6% | 17.4% | 17.2% | 26.8% |
| Debt to Equity | 0.32x | 0.50x | 0.35x | 0.21x | 0.13x | 0.45x | 0.35x | 0.33x | 0.33x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Top Choice Medical Investment Co Inc dividends
- Dividend yield
- 1.25%
- Forward dividend
- -
- Payout ratio
- 41.6%
- Ex-dividend date
- Jun 18, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 209M | 0.47 | 41.6% |
| 2024 | CNY 150M | 0.33 | 29.9% |
| 2023 | CNY 11.2M | 0.04 | 2.2% |
| 2022 | CNY 6.69M | 0.02 | 1.2% |
| 2021 | CNY 12.9M | 0.04 | 1.8% |
| 2020 | CNY 21.1M | 0.07 | 4.3% |
| 2019 | CNY 22.6M | 0.07 | 4.9% |
| 2018 | CNY 35.8M | 0.11 | 10.8% |
| 2017 | CNY 54.9M | 0.17 | 25.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.400595:1 on Jul 5, 2024.
Who owns Top Choice Medical Investment Co Inc
- Insiders 37.06%
- Institutions 9.23%
- Public & others 53.70%
- Shares outstanding 444M
- Free float 288M
Top Choice Medical Investment Co Inc company profile
- Company name
- Top Choice Medical Investment Co Inc
- Ticker
- 600763.SHG
- ISIN
- CNE000000MZ8
- Exchange
- Shanghai Stock Exchange
- Listed since
- Oct 21, 1996
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 6,224
- Fiscal year end
- December
- Address
- No. 1 Tongce Medical Building, Hangzhou, China, 310023
- Phone
- 86 571 8886 8808
- Website
- tcmedical.com.cn
About Top Choice Medical Investment Co Inc
Topchoice Medical Co., Inc. offers oral medical services in China. The company is involved in the sale of medical equipment, daily necessities, disinfection products, investment management, import and export business, technology development, technology consulting and technology services, and training services, as well as offers dental medical services. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Co., Inc. in November 2019. Topchoice Medical Co., Inc. was incorporated in 1995 and is based in Hangzhou, China.
Top Choice Medical Investment Co Inc management
4- Ms. Yi WangGM & Chairman · born 1968
- Mr. Guoxi XuCFO & Accounting Supervisor · born 1985
- Mr. Hua ZhangSecretary of the Board · born 1965
- Liang HaoCompany Representative